Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2000
03/23/2000CA2341440A1 Novel compounds
03/22/2000EP0987552A2 Diarylsulfonylurea binding proteins
03/22/2000EP0987256A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/22/2000EP0986386A2 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
03/22/2000EP0986314A1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids
03/22/2000CN1248288A Nuclear trasfer with differentiated fetal and adult donor cells
03/22/2000CN1248257A Compound for inhibition of gastric acid secretion
03/22/2000CN1248162A Topical pharmaceutical composition comprising cholinergic agent or calcium channel blocker
03/22/2000CN1248155A Compositions to control oral microbial oxidation-reduction (Eh) levels
03/22/2000CN1247755A Hepatitis treating medicine and its production process
03/22/2000CN1247753A Toothache pill (powder)
03/22/2000CN1247751A Chinese medicine for treating calculus hydrops of liver, gall and kidney
03/22/2000CN1247744A Medicine powder for treating hepatitis A and hepatitis B
03/22/2000CN1050605C Cycloalkano-indole and -azaindole derivatives, its prepn. and medical composition containing them
03/21/2000US6040451 Used as analgesic, sedative and anaesthetic agents
03/21/2000US6040432 Metal complexes, of DTPA derivatives suitable for use in diagnosis and therapy
03/21/2000US6040329 Substituted indazole analogs
03/21/2000US6040328 Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
03/21/2000US6040321 Enzyme inhibitor treating cancer, inflammation and arthritis, neurodegenerative diseases such as alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases
03/21/2000US6040310 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
03/21/2000US6040303 7-phenyl-1, 4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them
03/21/2000CA2146097C 1h-indole-3-glyoxylamide spla2 inhibitors
03/21/2000CA2132745C Novel cardioprotective agents
03/16/2000WO2000014263A2 Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
03/16/2000WO2000014262A2 Methylation of plasmid vectors
03/16/2000WO2000014235A1 Kunitz domain polypeptide zkun6
03/16/2000WO2000014222A2 GABAB RECEPTOR SUBTYPES GABAB-R1c AND GABAB-R2 AND HETERODIMERS THEREOF
03/16/2000WO2000014114A1 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants
03/16/2000WO2000014097A2 Novel pyranoses
03/16/2000WO2000014086A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000WO2000014083A1 SUBSTITUTED η-PHENYL-Δ-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO
03/16/2000WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity
03/16/2000WO2000013707A1 Preventives/remedies for multiple organ failure
03/16/2000WO2000013694A1 Gcp
03/16/2000WO2000013689A1 Methods and compositions for increasing intestinal absorption of fats
03/16/2000WO2000013667A1 Lipstatin derivative-soluble fiber tablets
03/16/2000WO2000013531A2 Composition comprising a viscosity modulating polymer material and its use
03/16/2000WO2000002582A3 Treatment of celiac disease with interleukin-15 antagonists
03/16/2000WO1999067363A9 Ependymal neural stem cells and method for their isolation
03/16/2000WO1999061471A3 Human transmembrane proteins
03/16/2000WO1999055706A9 Imidazo pyridine derivatives which inhibit gastric acid secretion
03/16/2000CA2342882A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000CA2342855A1 Novel pyranoses
03/16/2000CA2342796A1 Preventives/remedies for multiple organ failure
03/16/2000CA2342625A1 Lipstatin derivative-soluble fiber tablets
03/16/2000CA2342284A1 Methylation of plasmid vectors
03/16/2000CA2338384A1 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants
03/15/2000EP0985149A1 Methods for evaluating tissue morphogenesis and activity
03/15/2000EP0985052A1 METHODS AND COMPOSITIONS TO IDENTIFY SWINE GENETICALLY RESISTANT TO F18 $i(E. COLI) ASSOCIATED DISEASES
03/15/2000EP0984981A1 Anti-inflammatory tyrosine derivatives
03/15/2000EP0984969A1 Fused dihydropyrans
03/15/2000EP0984966A1 9-AZABICYCLO(3.3.1)NON-2-ENE AND NONANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACh RECEPTORS
03/15/2000EP0984965A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
03/15/2000EP0984963A1 Novel compounds
03/15/2000EP0984960A1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984957A1 NOVEL FORM OF $i(S)OMEPRAZOLE
03/15/2000EP0984955A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNF$g(a) LEVELS
03/15/2000EP0984952A1 A new salt
03/15/2000EP0984930A1 2-indolinone derivatives as modulators of protein kinase activity
03/15/2000EP0984782A2 Use of anti-inflammatory steroids for the treatment of chronic inflammatory intestinal diseases
03/15/2000EP0984779A1 Somatostatin agonists
03/15/2000EP0984774A1 Gastroretentive controlled release microspheres for improved drug delivery
03/15/2000EP0984773A1 Pharmaceutical formulation of omeprazole
03/15/2000EP0783504B1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE AS ANTAGONISTS OF AMPA-RECEPTORS
03/15/2000EP0567566B1 Methods for treating tumor necrosis factor mediated diseases
03/15/2000EP0541726B1 Growth factor compositions, preparation and use
03/15/2000CN1247531A Arylsulfonyl hydroxamic acid derivatives
03/15/2000CN1247470A Method of using cycloxygenase-2 inhibitors as anti-angiogenic agents
03/15/2000CN1247091A Freeze-dired attenuated live vaccine for hepatitis A and its preparing process
03/15/2000CN1247087A Musk plaster and Fugan pill for treating hepatitis and cirrhosis
03/15/2000CN1247081A Chaiqi injection for treating viral hepatitis
03/15/2000CN1247080A Enteric coated particles and its preparing process
03/15/2000CN1050283C Gel-type cosmetic composite
03/14/2000US6037472 For treating disease-states characterized by excessive activity of matrix metalloproteases such as rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis
03/14/2000US6037377 Antiinflammatory agents and antiallergens
03/14/2000US6037342 Serotonin 5-HT3 receptor partial activator
03/14/2000US6037324 Madcam-1 (mucosal addressin cell adhesion molecule-1); useful in the treatment of inflammatory bowel diseases and other diseases involving leukocyte infiltration of the gastrointestinal tract or other mucosal tissues
03/14/2000US6036978 Antiinflammatory agents for gastrointestinal disorders
03/14/2000US6036956 Method and dosage form using an antagonist to gamma interferon to control MHC-associated autoimmune disease
03/14/2000US6036950 Administering immunogenic preparation of cells
03/14/2000CA2117643C Indole derivatives
03/14/2000CA2010778C Bioactive agents, compositions and materials comprising said bioactive agents
03/09/2000WO2000012739A1 Methods and compositions for expressing heterologous genes in hepatocytes using hepadnaviral vectors
03/09/2000WO2000012720A2 Elongase genes and uses thereof
03/09/2000WO2000012682A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000WO2000012514A1 Novel compounds
03/09/2000WO2000012510A1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
03/09/2000WO2000012502A1 Pyrroloquinolines for treatment of obesity
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012497A2 Quinazoline derivatives as medicaments
03/09/2000WO2000012488A1 Pyrazine compounds
03/09/2000WO2000012481A2 Indazole derivatives with 5-ht2 receptor activity________________
03/09/2000WO2000012477A1 Hydroxamic acid derivatives as proteinase inhibitors
03/09/2000WO2000012475A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000WO2000012467A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them
03/09/2000WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
03/09/2000WO2000012111A2 Selective treatment of endothelial somatostatin receptors
03/09/2000WO2000012108A1 Dry extract of henna, method for producing said extract and use of the same
03/09/2000WO2000012107A1 Composition containing pyrrolizidine-alkaloid-free petasites
1 ... 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 ... 1258